Genome editing is a technique which involves insertion, deletion or replacement of DNA at a specific site in the genome of a cell or organism. The global genome engineering market report has been segmented on the basis of technology, application, end user, and region. Technological advancements for development of novel vectors is major factors expected to drive the market growth over the forecast period. Increasing prevalence of cancer, infectious diseases and other genetic disorders is expected to boost the market growth over the forecast period.
Application segment includes cell line engineering and genetic engineering. The cell line engineering dominates the genome engineering market over the forecast period owing to the increasing focus by manufacturing companies on development of products which involves use of stem cell therapy and gene therapy and growing awareness about the cell line genetic engineering.
End user segment includes pharmaceutical and biotechnological companies, research and academic institutions, and clinical research organizations. The pharmaceutical and biotechnological companies segment contributes major market share owing to the increasing prevalence of cancer and infectious diseases as well as high adoption of advance technologies by these companies.
Get Sample Copy Of This Report: https://marketresearch.biz/report/genome-engineering-market/request-sample/
Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to the high adoption of advance techniques and increasing prevalence of cancer and other infectious diseases in the region. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like India, China, Japan is expected to support the growth of Asia Pacific, owing to the increasing government funding for research and development.
Some prominent players in the global genome engineering market are Thermo Fisher Scientific, New England Biolabs, OriGene Technologies, Inc., bluebird bio, Inc., Takara Bio USA, Inc., Cellectis S.A., Precision Biosciences, Inc., Sangamo Therapeutics, Inc., Merck KGaA, and Lonza Group Ltd.